Affiliation:
1. IVIRMA Global Research Alliance, 9.Baby, Bologna, Italy
2. IVIRMA Global Research Alliance, Extra omnes, Cattolica (RN), Italy
3. Univ. Hosp. UOC kidney and pancreas transplant company Regional Diabetes Cell Therapy Center PD IT
Abstract
Chronic viral infections are considered a risk factor for male fertility given their ability to infect semen. Several studies have shown that semen parameters and gamete DNA integrity can be compromised by human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. These effects on male fertility are also associated with other types of infection, such as human papillomavirus. To date, European directives for viral screening of couples undergoing assisted reproduction treatment requires evaluation only for the three most common infections: HIV, HBV and HCV. In all these cases it is essential that all operators involved in the laboratory are aware of the risk to themselves and to the patients treated, and also of the risk associated with the possibility of cross-contamination with other patients. In IVF centres, specific procedures must be established and respected in the case of serodiscordant couples, in order to guarantee correct management and treatment of biological samples. We can reduce or minimise the risk of cross-contamination by applying specific laboratory protocols for the safe handling of gametes and embryos. This mini review aims to describe the impact of viral infection on sperm and male fertility and the protocols and recommendations for the management of gametes from serodiscordant couples with infectious diseases. KEY WORDS: Serodiscordant, IVF, cross-contamination, procedures, male infertility, sexual transmission, sperm, viruses.
Reference44 articles.
1. 1. Edelstein MC, Kruithoff C, Brothman L, Veeck LL, Alexander NJ, Muasher SJ. The prevalence of human immunodeficiency virus in patients and their spouse entering a large in vitro fertilization program. J In Vitro Fert Embryo Transf. 1990;7(5):254-6.
2. 2. Abusheikha N, Akagbosu F, Marcus S, Lass A, Cousins C, Brinsden P. Viral screening and assisted conception treatment--the Bourn Hall experience. J Assist Reprod Genet. 1999;16(6):337-9.
3. 3. European Directorate for the Quality of Medicines & Healthcare. Guide to the quality and safety of tissues and cells for human application. European Commitee on Organ Trasplantation. Council of Europe; 5th edition, 2022.
4. 4. Shapiro H, Zaman L, Kennedy VL, Dean N, Yudin MH, Loutfy M. Managing and preventing blood-borne viral infection transmission in assisted reproduction: a Canadian Fertility and Andrology Society clinical practice guideline. Reprod Biomed Online. 2020;41(2):203-16.
5. 5. ESHRE Guideline Group on Viral infection/disease; Mocanu E, Drakeley A, Kupka MS, et al. ESHRE guideline: medically assisted reproduction in patients with a viral infection/disease. Hum Reprod Open. 2021;2021(4):hoab037.